ArticleMedicine2018

Using the recurrence risk score by Joensuu to assess patients with gastrointestinal stromal tumor treated with adjuvant imatinib: A retrospective cohort study.

Jianwei Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.